Resistant variants are often formed when susceptible Enterobacteriaceae are grown in media containing mecillinam. These variants have not yet been detected in patients or identified as a cause of treatment failure in limited clinical trials. Mecillinam-resistant organisms were formed by 5 out of 13 urinary isolates of Enterobacteriaceae incubated in urine containing mecillinam. The mean generation time of these five variants in urine containing therapeutic concentrations of mecillinam was 3.2 times that of normal organisms in antibiotic-free urine. When three of these five resistant variants were subcultured in antibiotic-free urine, the generation time, morphology, and antibiotic susceptibility returned to normal. On antibiotic-free agar medium, all five mecillinam-resistant variants readily reverted to the "susceptible" form and were therefore more likely to be phenotypic rather than genotypic mutants. In a second series of experiments, the flushing effect of the bladder on the clearance of organisms was partly simulated by frequent subculture in urine. Under these conditions, the cell density of cultures of all bacteria remained high during 10 subcultures over 52 h. However, bacterial populations progressively decreased in urine containing mecillinam until none could be detected at 28 h or thereafter. The slow growth rate of mecillinam-resistant variants may explain why detectable numbers of these organisms fail to colonize the urinary tract during treatment. Other factors may reinforce the postulated effect of the reduced growth rate in vivo.
Pivmecillinam, the oral ester of the amidinopenicillin mecillinam, is active against many Enterobacteriaceae (2, 5-7, 10-13, 16-19, 21-25) . Mecillinam-resistant variants (11, 13, 15, 16, 21) with an abnormal morphology are often isolated in the laboratory in the presence of antibiotic. These revert to the normal "susceptible" form on subculture in the absence of mecillinam. The value of this antibiotic might be reduced if resistant variants were formed in vivo. Fortunately, these resistant forms have not yet been detected in the feces (2, 7, 12) or urine of individuals receiving therapeutic doses of pivmecillinam, and clinical trials have shown it to be effective against urinary infections (5, 6, 23, 25) . The antibacterial activity and chemical stability of mecillinam are very dependent upon the growth medium (11, 17, 18, 21, 22) ; variations in inoculum density may also affect its activity (11, [16] [17] [18] 22) . The outcome of urinary tract infections is mainly determined by urinary antibiotic concentrations and activity (evidence reviewed in reference 1). The response of Enterobacteriaceae to mecillinam has therefore been studied here under conditions simulating some features of growth in the urinary bladder.
MATERIALS AND METHODS Antibiotic assay. Mecillinam concentrations were determined in triplicate with appropriate dilutions of urine by a large-plate assay system, using Escherichia coli as the indicator organism (3).
Preparation of urine for growth studies. Urine from volunteers on a normal alcohol-free diet was sterilized by filtration and stored at 40C for up to 25 h.
Organisms and antibiotic susceptibility tests. The 13 Enterobacteriaceae listed in Table 2 were isolated from patients with significant urinary tract infections. Bacteria were identified by the API 20 Enterobacteriaceae system (Analytab Products Inc., Plainview, N.Y. The materials and methods used for the determination of single-cell minimal inhibitory concentrations (MICs) have been described in detail elsewhere (2 In the presence of mecillinam, these five cultures also reached significantly lower mean bacterial densities than did their susceptible progenitors after growth for 24 h (3.7 x 108 against 1.6 x 109 organisms per ml; P < 0.01 by the two-tailed Welch test [14] Examination by phase-contrast microscopy showed that both the resistant variants and susceptible organisms being killed by mecillinam had the characteristic spherical form found on laboratory media (11, 15, 16, 21) .
Failure to detect mecillinam-resistant variants during frequent subculture in urine containing therapeutic concentrations of mecillinam. Some of the hydrodynamic features of the urinary bladder may be reproduced by serial dilution of cultures at the intervals at which urine is voided (8) . Cultures of bacteria in urine were therefore diluted 1:100 at intervals of 4 h over a period of 52 h, except that the dilutions due at 4 a.m. were omitted to represent the longer potential growth period occurring during sleep.
In the absence of antibiotic, all organisms grew rapidly and maintained dense cultures. Bacterial populations followed the general pattern shown in the representative selection of results in Table 2 ; the mean density of these cultures at 52 h was 6.8 (SD ± 3.4) x 108 organisms per ml. By contrast, all organisms were killed in urine containing mecillinam, and no viable bacteria were detected at 28 h or (25) .
Therapeutic concentrations of mecillinam in urine (Table 2) or lower concentrations in laboratory media (22) kill urinary organisms much more slowly than do corresponding concentrations of ampicillin in parallel experiments (4, 22) . However, mecillinam resistance is much less common than ampicillin resistance in clinical isolates of urinary Enterobacteriaceae (2) , and this may be an overriding consideration in practice. (16) .
Likewise, the failure to find mecillinam-resistant variants in feces (2, 12) is not surprising in the competitive environment of the gut, where Enterobacteriaceae are outnumbered more than 10,000:1 by anaerobes (9) .
